Skip to Content
Merck
  • Cre recombination-mediated cassette exchange for building versatile transgenic human embryonic stem cells lines.

Cre recombination-mediated cassette exchange for building versatile transgenic human embryonic stem cells lines.

Stem cells (Dayton, Ohio) (2009-05-06)
Zhong-Wei Du, Bao-Yang Hu, Melvin Ayala, Brian Sauer, Su-Chun Zhang
ABSTRACT

To circumvent the silencing effect of transgene expression in human embryonic stem cells (hESCs), we employed the Cre recombination-mediated cassette exchange strategy to target the silencing-resistant site in the genome. We have identified new loci that sustain transgene expression during stem cell expansion and differentiation to cells representing the three germ layers in vitro and in vivo. The built-in double loxP cassette in the established master hESC lines was specifically replaced by a targeting vector containing the same loxP sites, using the cell-permeable Cre protein transduction method, resulting in successful generation of new hESC lines with constitutive functional gene expression, inducible transgene expression, and lineage-specific reporter gene expression. This strategy and the master cell lines allow for rapid production of transgenic hESC lines in ordinary laboratories.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Safe Harbor Landing Pad Cell Line Jurkat T-Lymphocytes
Sigma-Aldrich
Safe Harbor Landing Pad Cell Line THP-1 Monocytes
Sigma-Aldrich
Safe Harbor Landing Pad Cell Line A549 Cancer Cells
Sigma-Aldrich
Safe Harbor Landing Pad Cell Line A375 Cancer Cells
Sigma-Aldrich
Safe Harbor Landing Pad Cell Line HCT-116 Cancer Cells